b
r
c
aim
determin
frequenc
viral
pathogen
caus
upper
respiratori
tract
infect
nonhospit
symptomat
adult
citi
rio
de
janeiro
method
respiratori
sampl
nasalthroat
swab
collect
august
novemb
real
time
pcr
use
detect
differ
viral
pathogen
result
virus
detect
sampl
patient
specif
posit
hbov
posit
hadv
posit
hrv
posit
flubv
hmpv
singl
infect
hrsva
detect
one
sampl
coinfect
detect
sampl
peak
viral
infect
observ
march
april
may
august
octob
howev
posit
sampl
detect
year
round
posit
sampl
collect
patient
febril
ill
conclus
result
present
report
suggest
respiratori
viral
infect
larg
diagnos
immunocompet
adult
although
major
young
adult
infect
lifethreaten
may
impos
signific
burden
especi
develop
countri
sinc
individu
repres
larg
fraction
work
forc
acut
respiratori
infect
repres
signific
morbid
mortal
burden
worldwid
caus
major
data
collect
regard
infect
children
epidemiolog
communityacquir
viral
respiratori
infect
among
adult
insuffici
perhap
except
infect
caus
influenza
viru
data
avail
focus
specif
popul
immunosuppress
homeless
elderli
individu
virus
lead
caus
acut
respiratori
diseas
throughout
world
caus
agent
respiratori
diseas
human
includ
human
respiratori
syncyti
viru
hrsv
human
parainfluenza
viru
hpiv
influenza
viru
fluav
influenza
b
viru
flubv
human
adenoviru
hadv
human
coronaviru
hcov
human
rhinoviru
hrv
human
metapneumoviru
hmpv
human
bocaviru
hbov
addit
two
human
polyomavirus
hpyv
kipyv
wupyv
detect
patient
respiratori
infect
brazilian
ministri
health
establish
countrywid
surveil
system
respiratori
viral
infect
system
compris
network
sentinel
unit
includ
outpati
clinic
emerg
care
depart
gener
hospit
issu
weekli
report
use
onlin
system
inform
total
number
visit
number
visit
associ
influenzalik
ill
ili
defin
case
fever
accompani
cough
sore
throat
diagnosi
system
design
detect
small
number
viru
speci
includ
fluav
flubv
hrsv
hadv
infect
caus
import
viral
pathogen
hpmv
hrv
hbov
hcov
monitor
aim
studi
determin
frequenc
type
upper
respiratori
viral
infect
nonhospit
adult
citi
rio
de
janeiro
brazil
period
two
year
use
molecular
diagnost
method
immunocompet
patient
n
attend
immunolog
servic
hospit
clementino
fraga
filho
hucff
feder
univers
rio
de
janeiro
ufrj
august
novemb
median
age
year
rang
year
enrol
present
studi
age
distribut
subject
follow
six
year
old
year
old
year
old
year
old
year
old
year
old
tabl
respiratori
sampl
nasalthroat
swab
obtain
particip
follow
collect
swab
place
viral
transport
media
store
c
process
relev
clinic
inform
includ
age
sex
clinic
symptom
collect
medic
visit
use
standard
questionnair
respiratori
ill
defin
presenc
rhinorrhea
andor
cough
andor
respiratori
distress
andor
sore
throat
without
fever
nucleic
acid
extract
l
collect
sampl
use
wizard
genom
dna
purif
kit
promega
madison
wi
total
rna
kit
appli
biosystemsambion
grand
island
ny
accord
manufactur
instruct
specimen
test
presenc
fluav
flubv
hrsv
variant
b
hpiv
speci
hrv
speci
b
hrvab
hmpv
hadv
hbov
speci
wupyv
kipyv
hcov
speci
real
time
pcr
assay
genom
rna
fluv
hrsv
hpiv
hrv
hmpv
hcov
subject
one
cycl
revers
transcript
min
c
follow
min
c
use
pmol
random
primer
hexam
pd
n
life
technolog
carlsbad
ca
usa
veriti
well
appli
biosystem
foster
citi
ca
usa
thermocycl
prior
pcr
amplif
realtim
pcr
amplif
perform
viru
separ
abi
stepon
realtim
pcr
system
appli
biosystem
amplif
condit
consist
min
c
follow
cycl
c
c
amplif
carri
l
reaction
volum
includ
l
dna
specif
primer
viru
l
maxima
sybr
green
qpcr
master
mix
fermentasthermo
fischer
scientif
canada
pcr
assay
hmpv
hrvab
hadv
kipyv
wupyv
use
singl
pair
primer
multiplex
assay
use
detect
discrimin
distinct
speci
fluv
hrsv
hbov
hipv
hcov
convent
rtpcr
protocol
use
detect
hrv
speci
c
hrvc
revers
transcript
step
viral
cdna
subject
one
step
min
c
follow
patient
n
male
femal
present
respiratori
ill
symptom
enrol
present
studi
respiratori
sampl
n
collect
analyz
presenc
virus
common
symptom
observ
cough
sneez
nasal
congest
fever
report
respiratori
infect
episod
fig
patient
stratifi
six
age
group
tabl
overal
detect
frequenc
viral
respiratori
infect
individu
year
old
frequenc
symptom
tabl
virusposit
sampl
collect
patient
febril
ill
seven
n
patient
present
hrv
four
posit
hrvab
three
hrvc
pronounc
symptom
cough
sneez
nasal
congest
wateri
eye
rhinorrhea
fever
fig
symptom
similar
infect
caus
hrvab
hrvc
hadv
detect
sampl
patient
present
singl
infect
sampl
four
patient
coinfect
kipyv
hrvab
frequent
symptom
present
patient
infect
hadv
cough
sneez
nasal
congest
myalgia
fig
patient
infect
hbov
consid
singl
coinfect
five
patient
infect
four
singl
infect
one
coinfect
hadv
infect
eight
patient
singl
infect
three
coinfect
hrvab
kipyv
hadv
common
symptom
observ
among
hbov
singleinfect
patient
cough
sneez
nasal
congest
rhinorrhea
fig
clinic
symptom
similar
infect
fluvb
detect
two
patient
old
femal
present
cough
myalgia
old
femal
present
cough
sneez
water
eye
nasal
congest
sore
throat
two
hmpv
infect
detect
first
case
old
femal
cough
sneez
nasal
congest
myalgia
second
old
femal
cough
rhinorrhea
nasal
congest
sore
throat
detect
singl
infect
yearold
male
present
cough
nasal
congest
coinfect
hadv
detect
old
femal
cough
sore
throat
rhinorrhea
sneez
nasal
congest
myalgia
old
male
present
fever
cough
sore
throat
infect
hrsva
old
femal
patient
infect
present
cough
rhinorrhea
sneez
nasal
congest
sore
throat
kipyv
detect
coinfect
tabl
peak
viral
infect
observ
primarili
march
n
april
posit
n
may
n
august
posit
n
octob
posit
n
howev
virus
detect
sampl
year
round
sampl
collect
month
januari
decemb
one
sampl
collect
novemb
fig
frequenc
respiratori
viral
infect
rvi
immunocompet
adult
often
overlook
howev
avail
data
suggest
rvi
respons
signific
number
respiratori
infect
affect
elderli
person
age
year
also
young
adult
although
major
infect
young
adult
lifethreaten
impos
signific
burden
commun
sinc
affect
popul
repres
larg
fraction
work
forc
develop
countri
data
present
report
indic
virusposit
sampl
detect
patient
year
age
brazil
avail
data
adult
rvi
restrict
immunocompromis
elderli
patient
littl
data
collect
rvi
present
immunocompet
adult
previous
demonstr
hadv
infect
detect
hrsv
hbov
hmpv
fluav
flubv
transplant
patient
hrv
hmpv
detect
respect
elderli
patient
even
studi
perform
porto
alegr
southern
brazil
novemb
octob
report
infect
immunocompet
adult
patient
median
age
year
age
admit
emerg
room
ili
sever
acut
respiratori
infect
sari
caus
respiratori
virus
mostli
fluav
hrvab
fluvb
hadv
hpiv
hrsv
hmpv
hcov
less
frequent
detect
present
studi
overal
frequenc
viru
detect
discrep
detect
rate
could
attribut
differ
methodolog
use
exampl
former
studi
sampl
test
use
indirect
immunofluoresc
assay
ifa
sampl
test
use
convent
pcr
assay
compar
use
convent
real
time
pcr
assay
detect
viru
isol
present
studi
sentinel
surveil
system
brazil
focus
monitor
infect
caus
fluav
flubv
respiratori
virus
hadv
hpiv
hrsv
hrvab
sampl
sent
test
public
health
laboratori
state
ifa
posit
inconclus
neg
sampl
forward
one
three
nation
refer
laboratori
retest
pcr
respiratori
virus
brazilian
surveil
system
record
case
ili
case
total
ili
visit
nasopharyng
sampl
collect
test
viral
infect
total
test
sampl
patient
year
age
posit
respiratori
virus
overal
fluav
common
virus
detect
howev
detect
rate
fluav
declin
period
studi
hadv
hbov
hrv
common
virus
detect
flubv
detect
test
sampl
fluav
detect
underscor
fluv
detect
among
patient
year
age
influenza
vaccin
brazil
freeli
distribut
risk
individu
includ
pregnant
women
gestat
age
women
day
childbirth
children
six
month
two
year
age
peopl
year
age
person
chronic
noncommunic
diseas
nativ
indian
healthcar
worker
accord
ministri
health
influenza
vaccin
coverag
brazil
reach
target
popul
may
explain
declin
fluv
detect
year
low
frequenc
fluv
infect
found
studi
lima
et
al
collect
sampl
august
august
detect
fluav
flubv
sampl
use
real
time
pcr
acut
viral
respiratori
diseas
surveil
program
around
world
monitor
case
febril
ili
therefor
patient
present
respiratori
symptom
without
fever
usual
includ
survey
present
studi
use
broader
definit
respiratori
ill
includ
patient
without
fever
afebril
patient
account
virusposit
sampl
identifi
suggest
respiratori
viru
infect
larg
undiagnos
particularli
among
immunocompet
adult
studi
support
part
conselho
nacion
de
desenvolvimento
e
cnpq
grant
number
de
oamento
de
pessoal
de
superior
cape
carlo
chaga
de
amparo
pesquisa
estado
rio
de
janeiro
faperj
grant
number
brazil
author
declar
conflict
interest
